OBJECTIVE: To test the effectiveness of a stepped care intervention modeltargeting posttraumatic stress disorder (PTSD) symptoms after injury. BACKGROUND: Few investigations have evaluated interventions for injured patients with PTSD and related impairments that can be feasibly implemented in trauma surgical settings. METHODS: The investigation was a pragmatic effectiveness trial in which 207 acutely injured hospitalized trauma survivors were screened for high PTSD symptom levels and then randomized to a stepped combined care management, psychopharmacology, and cognitive behavioral psychotherapy intervention (n = 104) or usual care control (n = 103) conditions. The symptoms of PTSD and functional limitations were reassessed at 1, 3, 6, 9, and 12 months after the index injury admission. RESULTS: Regression analyses demonstrated that over the course of the year after injury, intervention patients had significantly reduced PTSD symptoms when compared with controls [group by time effect, CAPS (Clinician-Administered PTSD Scale): F(2, 185) = 5.50, P < 0.01; PCL-C (PTSD Checklist Civilian Version): F(4, 185) = 5.45, P < 0.001]. Clinically and statistically significant PTSD treatment effects were observed at the 6-, 9-, and 12-month postinjury assessments. Over the course of the year after injury, intervention patients also demonstrated significant improvements in physical function [MOS SF-36 PCS (Medical Outcomes Study Short Form 36 Physical Component Summary) main effect: F(1, 172) = 9.87, P < 0.01]. CONCLUSIONS:Stepped care interventions can reduce PTSD symptoms and improve functioning over the course of the year after surgical injury hospitalization. Orchestrated investigative and policy efforts could systematically introduce and evaluate screening and intervention procedures for PTSD at US trauma centers. ( TRIAL REGISTRATION: clinicaltrials.gov identifier: NCT00270959).
RCT Entities:
OBJECTIVE: To test the effectiveness of a stepped care intervention model targeting posttraumatic stress disorder (PTSD) symptoms after injury. BACKGROUND: Few investigations have evaluated interventions for injured patients with PTSD and related impairments that can be feasibly implemented in trauma surgical settings. METHODS: The investigation was a pragmatic effectiveness trial in which 207 acutely injured hospitalized trauma survivors were screened for high PTSD symptom levels and then randomized to a stepped combined care management, psychopharmacology, and cognitive behavioral psychotherapy intervention (n = 104) or usual care control (n = 103) conditions. The symptoms of PTSD and functional limitations were reassessed at 1, 3, 6, 9, and 12 months after the index injury admission. RESULTS: Regression analyses demonstrated that over the course of the year after injury, intervention patients had significantly reduced PTSD symptoms when compared with controls [group by time effect, CAPS (Clinician-Administered PTSD Scale): F(2, 185) = 5.50, P < 0.01; PCL-C (PTSD Checklist Civilian Version): F(4, 185) = 5.45, P < 0.001]. Clinically and statistically significant PTSD treatment effects were observed at the 6-, 9-, and 12-month postinjury assessments. Over the course of the year after injury, intervention patients also demonstrated significant improvements in physical function [MOS SF-36 PCS (Medical Outcomes Study Short Form 36 Physical Component Summary) main effect: F(1, 172) = 9.87, P < 0.01]. CONCLUSIONS: Stepped care interventions can reduce PTSD symptoms and improve functioning over the course of the year after surgical injury hospitalization. Orchestrated investigative and policy efforts could systematically introduce and evaluate screening and intervention procedures for PTSD at US trauma centers. ( TRIAL REGISTRATION: clinicaltrials.gov identifier: NCT00270959).
Authors: Charles W Hoge; Dennis McGurk; Jeffrey L Thomas; Anthony L Cox; Charles C Engel; Carl A Castro Journal: N Engl J Med Date: 2008-01-30 Impact factor: 91.245
Authors: Douglas Zatzick; Gregory J Jurkovich; Frederick P Rivara; Jin Wang; Ming-Yu Fan; Jutta Joesch; Ellen Mackenzie Journal: Ann Surg Date: 2008-09 Impact factor: 12.969
Authors: Murray A Raskind; Elaine R Peskind; David J Hoff; Kimberly L Hart; Hollie A Holmes; Daniel Warren; Jane Shofer; James O'Connell; Fletcher Taylor; Christopher Gross; Kirsten Rohde; Miles E McFall Journal: Biol Psychiatry Date: 2006-10-25 Impact factor: 13.382
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Francine Terrell; Douglas F Zatzick; Gregory J Jurkovich; Frederick P Rivara; Dennis M Donovan; Christopher W Dunn; Carol Schermer; Jay Wayne Meredith; Larry M Gentilello Journal: J Am Coll Surg Date: 2008-07-14 Impact factor: 6.113
Authors: Douglas F Zatzick; Gregory J Jurkovich; Ming-Yu Fan; David Grossman; Joan Russo; Wayne Katon; Frederick P Rivara Journal: Arch Pediatr Adolesc Med Date: 2008-07
Authors: Douglas F Zatzick; Frederick P Rivara; Avery B Nathens; Gregory J Jurkovich; Jin Wang; Ming-Yu Fan; Joan Russo; David S Salkever; Ellen J Mackenzie Journal: Psychol Med Date: 2007-06-11 Impact factor: 7.723
Authors: Erik G Van Eaton; Douglas F Zatzick; Thomas H Gallagher; Peter Tarczy-Hornoch; Frederick P Rivara; David R Flum; Roselyn Peterson; Ronald V Maier Journal: J Am Coll Surg Date: 2014-04-21 Impact factor: 6.113
Authors: Douglas F Zatzick; Ali Rowhani-Rahbar; Jin Wang; Joan Russo; Doyanne Darnell; Leah Ingraham; Lauren K Whiteside; Roxanne Guiney; Margot Kelly Hedrick; Frederick P Rivara Journal: Psychiatr Serv Date: 2017-02-01 Impact factor: 3.084
Authors: Neil P Roberts; Neil J Kitchiner; Justin Kenardy; Lindsay Robertson; Catrin Lewis; Jonathan I Bisson Journal: Cochrane Database Syst Rev Date: 2019-08-08
Authors: Carolyn A McCarty; Douglas Zatzick; Elizabeth Stein; Jin Wang; Robert Hilt; Frederick P Rivara Journal: Pediatrics Date: 2016-09-13 Impact factor: 7.124